Our primary research areas are:

• Mental Health (Psychiatry and Neurology),
• Cardiology,
• Gastroenterology and
• Women’s and men’s health.

Last year we devoted 17% of our aggregate revenues to new research and development. Our aim is to develop for the global market products that are innovative solutions to current medical problems. Reduction of development time is a priority, since time to market is essential to recoup the significant investments in R&D.

Our major R&D centers are located in Hanover (Germany), Weesp (The Netherlands), Marietta, GA (US) and Tokyo (Japan).